ASPIRIN: THE $0.10 PILL THAT JUST BEAT CANCER’S ODDS

A Scandinavian trial just found that low-dose aspirin halves the risk of colon and rectal cancer coming back – but only in patients with a specific genetic mutation.

3,500 patients across Sweden, Norway, Denmark, and Finland… https://t.co/v7acTp2QoF pic.twitter.com/vHWtO4mLCA

— Mario Nawfal (@MarioNawfal) October 4, 2025